2-hydroxy-3,6-dichlorobenzoic acid: structure; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 18844 |
| CHEMBL ID | 1233461 |
| SCHEMBL ID | 342262 |
| MeSH ID | M0069285 |
| Synonym |
|---|
| 3401-80-7 |
| AC-12116 |
| 2-oxy-3,6-dichlorobenzoic acid |
| 3,6-dichlorosalicylic acid |
| brn 2938787 |
| benzoic acid, 3,6-dichloro-2-hydroxy- |
| 2-hydroxy-3,6-dichlorobenzoic acid |
| einecs 222-275-8 |
| 3,6-dichloro-2-hydroxybenzoic acid |
| salicylic acid, 3,6-dichloro- |
| STL301577 |
| CHEMBL1233461 , |
| hxx , |
| AKOS000271099 |
| unii-4ybf44h2o7 |
| 3-10-00-00174 (beilstein handbook reference) |
| 4ybf44h2o7 , |
| AS-871/43380742 |
| F3284-8032 |
| FT-0614758 |
| SCHEMBL342262 |
| 3,6-dichloro-2-hydroxybenzoicacid |
| W-106755 |
| benzoic acid, 3,6-dichloro-2-hydroxy |
| DTXSID9041657 |
| GS-6081 |
| bdbm50489028 |
| 3,6-dichloro-2-hydroxy-benzoic acid, 97% |
| mfcd00155381 |
| dicamba-desmethyl |
| 3,6-dichloro-2-hydroxy benzoic acid |
| 3,6 dichlorosalicylic acid |
| AMY6419 |
| Q27260668 |
| A924520 |
| H10577 |
| dicamba-desmethyl 100 microg/ml in acetonitrile |
| CS-0157191 |
| EN300-322520 |
| Z367679284 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.19) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||